Hetlioz and Nexium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hetlioz (tasimelteon) and Nexium (esomeprazole magnesium). Common drug interactions include drug ineffective among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Hetlioz and Nexium. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.

What is Hetlioz?

Hetlioz has active ingredients of tasimelteon. eHealthMe is studying from 7,418 Hetlioz users. Check the latest studies of Hetlioz.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,678 Nexium users. Check the latest studies of Nexium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

86 people who take Hetlioz and Nexium together, and have interactions are studied.

Hetlioz and Nexium drug interactions.

What are the common drug interactions of Hetlioz and Nexium, by gender? *:

female:

  1. Drug ineffective
  2. Insomnia (sleeplessness)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  5. Headache (pain in head)
  6. Sleep disorder
  7. Abnormal dreams
  8. Diarrhoea
  9. Initial insomnia (feeling of inadequate or poor-quality sleep)
  10. Alopecia (absence of hair from areas of the body)

male:

  1. Drug ineffective
  2. Insomnia (sleeplessness)
  3. Sleep disorder
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Hospitalisation
  6. Localised infection (infection at the single location)
  7. Anticoagulation drug level below therapeutic
  8. Asthenia (weakness)
  9. Blood pressure increased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Hetlioz and Nexium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  3. Abnormal dreams
  4. Alopecia (absence of hair from areas of the body)
  5. Limb discomfort (discomfort in leg)
  6. Pain in extremity
  7. Pregnancy

40-49:

  1. Insomnia (sleeplessness)
  2. Drug ineffective
  3. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  4. Sleep disorder
  5. Abdominal discomfort
  6. Adverse drug reaction
  7. Depression
  8. Headache (pain in head)
  9. Initial insomnia (feeling of inadequate or poor-quality sleep)
  10. Blood pressure increased

50-59:

  1. Drug ineffective
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Hospitalisation
  4. Localised infection (infection at the single location)
  5. Anticoagulation drug level below therapeutic
  6. Asthenia (weakness)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Dyspepsia (indigestion)
  10. Ear infection

60+:

  1. Drug ineffective
  2. Insomnia (sleeplessness)
  3. Pneumonia
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Unresponsive to stimuli
  7. Headache (pain in head)
  8. Fall
  9. Memory impairment
  10. Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

  1. Circadian Rhythm Sleep Disorder (family of sleep disorders affecting, among other things, the timing of sleep): 32 people, 37.21%

* Approximation only. Some reports may have incomplete information.

Do you take Hetlioz and Nexium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hetlioz and Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hetlioz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hetlioz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tasimelteon and esomeprazole magnesium (the active ingredients of Hetlioz and Nexium, respectively), and Hetlioz and Nexium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: